A new treatment for obesity
A new medication for the treatment of obesity has been approved by the FDA, and it received significant media attention in the months leading up to its approval. A high-dose injectable hormone, it already existed in a different form as a treatment for type 2 diabetes, but in this form and dosage it has advantages over other available weight-loss medications, as well as its own potential risks.
Content restricted. Requires subscription